Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. short communication
  4. article
Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27
Download PDF
Download PDF
  • Short Communication
  • Open access
  • Published: 01 December 2005

Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27

  • Yun-Jee Seo1,
  • Mi-Hee Jeon,
  • Jung-Hee Lee,
  • Yong-Joon Lee,
  • Ho-Joong Youn,
  • Jeong Heon Ko &
  • …
  • Jeong-Hwa Lee 

Experimental & Molecular Medicine volume 37, pages 624–630 (2005)Cite this article

  • 1230 Accesses

  • 18 Citations

  • 3 Altmetric

  • Metrics details

Abstract

Bis (Bag-3, CAIR), a Bcl-2-interacting protein, promotes the anti-apoptotic activity of Bcl-2 and increased levels of Bis have been observed in several disease models. The involvement of Bcl-2 and some Bcl-2-binding proteins in differentiation has recently been reported. However, the relevance of Bis to cellular differentiation remains unknown. The findings herein show that Bis expression is up-regulated during the differentiation of HL-60 cells. To investigate the effect of Bis expression on differentiation, we established Bis-overexpressing HL-60 cells (HL-60-bis). HL-60-bis cells have a low nuclear: cytoplasmic ratio and indented nucleus in Wright- Giemsa staining, and an increased expression of CD11b in immunofluorescence study, indicating the promotion of differentiation. The overexpression of Bis also resulted in a retarded cell growth rate, accompanied by the accumulation of HL-60 cells at the G0/G1 phase of the cell cycle, which was sustained during the differentiation process. Western blot analysis revealed that the expression of p27, a representative inducer of cell cycle arrest at the G1 phase, was increased 2.5-fold in HL-60-bis cells compared to HL-60-neo cells. These results suggest that the Bis induced growth inhibition of HL-60 cells promotes G0/G1 phase arrest via up-regulation of p27, which seems to be a prerequisite for differentiation. Further studies will be required to define the exact roles of Bis on cellular differentiation more precisely.

Similar content being viewed by others

Bispecific antibody (ABL602 2 + 1) induced bistable acute myeloid leukemia kinetics

Article Open access 26 October 2024

Overcoming apoptotic resistance afforded by Bcl-2 in lymphoid tumor cells: a critical role for dexamethasone

Article Open access 20 December 2022

Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3

Article Open access 26 September 2024

Article PDF

Author information

Authors and Affiliations

  1. Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 137-701, Korea

    Yun-Jee Seo

Authors
  1. Yun-Jee Seo
    View author publications

    Search author on:PubMed Google Scholar

  2. Mi-Hee Jeon
    View author publications

    Search author on:PubMed Google Scholar

  3. Jung-Hee Lee
    View author publications

    Search author on:PubMed Google Scholar

  4. Yong-Joon Lee
    View author publications

    Search author on:PubMed Google Scholar

  5. Ho-Joong Youn
    View author publications

    Search author on:PubMed Google Scholar

  6. Jeong Heon Ko
    View author publications

    Search author on:PubMed Google Scholar

  7. Jeong-Hwa Lee
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Seo, YJ., Jeon, MH., Lee, JH. et al. Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27. Exp Mol Med 37, 624–630 (2005). https://doi.org/10.1038/emm.2005.76

Download citation

  • Published: 01 December 2005

  • Issue date: 01 December 2005

  • DOI: https://doi.org/10.1038/emm.2005.76

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • BAG3 protein, human
  • cell differentiation
  • cyclin-dependent kinase inhibitor p27
  • HL-60 cells

This article is cited by

  • Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia

    • Huayuan Zhu
    • Wei Wu
    • Jianyong Li

    Annals of Hematology (2014)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited